The effect of atorvastatin on CD36 expression in THP-1 macrophages
Jing-Tao Feng
Abstract
Jing-Tao Feng
Abstract
Objective To investigate the effect of atorvastatin on CD36 expression in THP-1 macrophages. Methods THP-1 macrophages were treated with 5 μmol/L atorvastatin for 0 h,3 h,6 h,12 h,24 h respectively. And THP-1 macrophages were treated with atorvastatin at different concentrations (0 μmol/L,0.625 μmol/L,1.25 μmol/L,2.5 μmol/L,5 μmol/L). CD36 mRNA and protein levels were determined by reverse transcription-polymerase chain reaction(RT-PCR) and Western blotting respectively. Results We found that atorvastatin decreased CD36 in both protein and mRNA levels in a time-dependent and dose-dependent manner. Conclusion Atorvastatin may down-regulate CD36 expression in THP-1 macrophages.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To investigate the effect of atorvastatin on CD36 expression in THP-1 macrophages. Methods THP-1 macrophages were treated with 5 μmol/L atorvastatin for 0 h,3 h,6 h,12 h,24 h respectively. And THP-1 macrophages were treated with atorvastatin at different concentrations (0 μmol/L,0.625 μmol/L,1.25 μmol/L,2.5 μmol/L,5 μmol/L). CD36 mRNA and protein levels were determined by reverse transcription-polymerase chain reaction(RT-PCR) and Western blotting respectively. Results We found that atorvastatin decreased CD36 in both protein and mRNA levels in a time-dependent and dose-dependent manner. Conclusion Atorvastatin may down-regulate CD36 expression in THP-1 macrophages.
Key concepts: Atorvastatin, CD36, THP1 cell line, Messenger RNA, Blot, Molecular biology, Reverse transcription polymerase chain reaction, Chemistry